CDC: Fatal Drug Overdoses More Than Doubled Since 1999

Share this content:
CDC: Fatal Drug Overdoses More Than Doubled Since 1999
CDC: Fatal Drug Overdoses More Than Doubled Since 1999

FRIDAY, Feb. 24, 2017 (HealthDay News) -- Drug overdose deaths have nearly tripled in the United States since 1999, with the largest increases seen for whites and middle-aged Americans, according to a February data brief published by the U.S. Centers for Disease Control and Prevention's National Center for Health Statistics.

Holly Hedegaard, M.D., of the National Center for Health Statistics in Hyattsville, Md., and colleagues note that 16.3 out of every 100,000 Americans died of a drug overdose in 2015, compared to 6.1 in 1999.

The researchers also found that drug overdose deaths have risen among whites at a rate of about 7 percent each year, compared with 2 percent a year for blacks and Hispanics. The overdose death rate among whites in 2015 was nearly 3.5 times the rate it was in 1999. Drug overdose deaths increased from 1999 to 2015 in all age groups, but adults aged 45 to 54 had the highest death rate -- 30 fatalities for every 100,000 people.

Heroin accounted for one-quarter of overdose deaths in 2015 -- triple the rate in 2010, Hedegaard told HealthDay. Other opioids -- both synthetic and natural -- such as oxycodone and hydrocodone accounted for another 24 percent of overdose deaths in 2015, down from 29 percent in 2010. Four states -- West Virginia, New Hampshire, Kentucky, and Ohio -- lead the nation with the highest overdose death rates, according to the report.

More Information

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

Social, Communication Delays With False-Negative on M-CHAT

Social, Communication Delays With False-Negative on M-CHAT

Delays for those who pass M-CHAT screening at 18 months but are later diagnosed with ASD

FDA Approves Aimovig to Prevent Migraines

FDA Approves Aimovig to Prevent Migraines

Patients taking Aimovig reported one to two fewer monthly migraine days than those taking pacebo

Risk of Dementia Up for Older Adults With Lowest Wealth

Risk of Dementia Up for Older Adults With ...

Increased risk seen independent of education, index of multiple deprivation, health indicators

is free, fast, and customized just for you!

Already a member?

Sign In Now »